Identified oncogene mutations in thyroid neoplasms mainly consist of BRAF and RAS. BRAF mutations are the most common genetic alteration occurring in thyroid carcinomas especially in PTC, accounting for 28–83%, with an overall rate of 44% (46–48). Here, BRAF is linked to thyroid tumor.